{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:32:24Z","timestamp":1761154344965,"version":"3.30.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,5,1]]},"DOI":"10.1093\/ndt\/15.5.659","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:40:19Z","timestamp":1027723219000},"page":"659-667","source":"Crossref","is-referenced-by-count":19,"title":["A new assay method that detects only intact osteocalcin. Two\u2010step non\u2010invasive diagnosis to predict adynamic bone disease in haemodialysed patients"],"prefix":"10.1093","volume":"15","author":[{"given":"Tetsuo","family":"Morishita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Saruta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2000,5]]},"reference":[{"key":"key\n\t\t\t\t20180109102455_R1","unstructured":"Malluche HH, Monier\u2010Faugere MC. Risk of adynamic bone disease in dialyzed patients. Kidney Int1992; 38 [Suppl]: S62\u2013S67"},{"key":"key\n\t\t\t\t20180109102455_R2","doi-asserted-by":"crossref","unstructured":"Sherrard DJ, Hercz G, Pei Y et al. The spectrum of bone disease in end\u2010stage renal failure\u2014an evolving disorder. Kidney Int1993; 43: 436\u2013442","DOI":"10.1038\/ki.1993.64"},{"key":"key\n\t\t\t\t20180109102455_R3","unstructured":"Akizawa T, Kinugasa E, Akiba T, Tsukamoto Y, Kurokawa K. Incidence and clinical characteristics of hypoparathyroidism in dialysis patients. Kidney Int1997; 52 [Suppl. 62]: S72\u2013S74"},{"key":"key\n\t\t\t\t20180109102455_R4","doi-asserted-by":"crossref","unstructured":"Qi Q, Monier\u2010Faugere MC, Geng Z, Malluche HH. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis1995; 26: 622\u2013631","DOI":"10.1016\/0272-6386(95)90599-5"},{"key":"key\n\t\t\t\t20180109102455_R5","doi-asserted-by":"crossref","unstructured":"Malluche HH, Faugere M\u2010C, Fanti P, Price PA. Plasma levels of bone Gla\u2010protein reflect bone formation in patients on chronic maintenance dialysis. Kidney Int1984; 26: 869\u2013874","DOI":"10.1038\/ki.1984.230"},{"key":"key\n\t\t\t\t20180109102455_R6","doi-asserted-by":"crossref","unstructured":"Epstein S, Traberg H, Raja R, Poser J. Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation. J Clin Endocrinol Metab1985; 60: 1253\u20131256","DOI":"10.1210\/jcem-60-6-1253"},{"key":"key\n\t\t\t\t20180109102455_R7","doi-asserted-by":"crossref","unstructured":"Coen G, Mazzaferro S, Bonucci E et al. Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long\u2010term follow\u2010up. Kidney Int1985; 28: 783\u2013790","DOI":"10.1038\/ki.1985.198"},{"key":"key\n\t\t\t\t20180109102455_R8","doi-asserted-by":"crossref","unstructured":"Charhon SA, Delmas PD, Malaval L et al. Serum bone Gla\u2010protein in renal osteodystrophy. comparison with bone histomorphometry. J Clin Endocrinol Metab1986; 63: 892\u2013897","DOI":"10.1210\/jcem-63-4-892"},{"key":"key\n\t\t\t\t20180109102455_R9","doi-asserted-by":"crossref","unstructured":"Mazzaferro S, Coen G, Ballanti P et al. Osteocalcin, iPTH, alkaline phosphatase and hand X\u2010ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy. Nephron1990; 56: 261\u2013266","DOI":"10.1159\/000186151"},{"key":"key\n\t\t\t\t20180109102455_R10","doi-asserted-by":"crossref","unstructured":"Martinez ME, Selgas R, Miguel JL, Balaguer G, Sanchez\u2010Cabezudo MJ, Llach F. Osteocalcin levels in uremic patients: influence of calcitriol treatment through two different routes and type of dialysis. Nephron1991; 59: 429\u2013433","DOI":"10.1159\/000186603"},{"key":"key\n\t\t\t\t20180109102455_R11","doi-asserted-by":"crossref","unstructured":"Ducy P, Desbois C, Boyce B et al. Increased bone formation in osteocalcin\u2010deficient mice. Nature1996; 382: 448\u2013452","DOI":"10.1038\/382448a0"},{"key":"key\n\t\t\t\t20180109102455_R12","doi-asserted-by":"crossref","unstructured":"Mikuni\u2010Takagaki Y, Kakai Y, Satoyoshi M et al. Matrix mineralization and the differentiation of osteocyte\u2010like cells in culture. J Bone Miner Res1995; 10: 231\u2013242","DOI":"10.1002\/jbmr.5650100209"},{"key":"key\n\t\t\t\t20180109102455_R13","doi-asserted-by":"crossref","unstructured":"Koshihara Y, Hoshi K, Ishibashi H, Shiraki M. Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3\u2010induced mineralization in human periosteal osteoblasts. Calcif Tissue Int1996; 59: 466\u2013473","DOI":"10.1007\/BF00369212"},{"key":"key\n\t\t\t\t20180109102455_R14","doi-asserted-by":"crossref","unstructured":"Ohgushi H, Dohi Y, Katuda T, Tamai S, Tabata S, Suwa Y. In vitro bone formation by rat marrow cell culture. J Biomed Mater Res1996; 32: 333\u2013340","DOI":"10.1002\/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T"},{"key":"key\n\t\t\t\t20180109102455_R15","doi-asserted-by":"crossref","unstructured":"Koshihara Y, Hoshi K. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res1997; 12: 431\u2013438","DOI":"10.1359\/jbmr.1997.12.3.431"},{"key":"key\n\t\t\t\t20180109102455_R16","doi-asserted-by":"crossref","unstructured":"Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin\u2010deficient mice provides insight into the function of osteocalcin. Bone1998; 23: 187\u2013196","DOI":"10.1016\/S8756-3282(98)00092-1"},{"key":"key\n\t\t\t\t20180109102455_R17","doi-asserted-by":"crossref","unstructured":"Hosoda K, Eguchi H, Nakamoto T et al. A sandwich immunoassay for intact human osteocalcin. Clin Chem1992; 38: 2233\u20132238","DOI":"10.1093\/clinchem\/38.11.2233"},{"key":"key\n\t\t\t\t20180109102455_R18","doi-asserted-by":"crossref","unstructured":"Faugere MC, Malluche HH. Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients. Kidney Int1986; 30: 717\u2013722","DOI":"10.1038\/ki.1986.246"},{"key":"key\n\t\t\t\t20180109102455_R19","unstructured":"Nebeker HG, Andress DL, Milliner DS et al. Indirect methods for the diagnosis of aluminum bone disease. plasma aluminum, the desferrioxamine infusion test, and serum iPTH. Kidney Int1986; 18 [Suppl]: S96\u2013S99"},{"key":"key\n\t\t\t\t20180109102455_R20","doi-asserted-by":"crossref","unstructured":"Malluche HH, Faugere M\u2010C. Atlas of Mineralized Bone Histology. Karger, Basel, 1986","DOI":"10.1159\/isbn.978-3-318-04339-6"},{"key":"key\n\t\t\t\t20180109102455_R21","doi-asserted-by":"crossref","unstructured":"Parfitt AM, Drezner MK, Glorieux FH et al. Bone histomorphometry. Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res1987; 2: 595\u2013610","DOI":"10.1002\/jbmr.5650020617"},{"key":"key\n\t\t\t\t20180109102455_R22","doi-asserted-by":"crossref","unstructured":"Garcia\u2010Carrasco M, Gruson M, De Vernejoul MC, Denne MA, Miravet L. Osteocalcin and bone morphometric parameters in adults. Calcif Tissue Int1988; 42: 13\u201317","DOI":"10.1007\/BF02555833"},{"key":"key\n\t\t\t\t20180109102455_R23","doi-asserted-by":"crossref","unstructured":"Sox HCJ. Probability theory in the use of diagnostic tests. Ann Intern Med1986; 104: 60\u201366","DOI":"10.7326\/0003-4819-104-1-60"},{"key":"key\n\t\t\t\t20180109102455_R24","doi-asserted-by":"crossref","unstructured":"Hanley JA, McNeil BJ. The meaning and use of the area under a Receiver Operating Characteristic (ROC) curve. Diagn Radiol1982; 143: 29\u201336","DOI":"10.1148\/radiology.143.1.7063747"},{"key":"key\n\t\t\t\t20180109102455_R25","doi-asserted-by":"crossref","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer1950; 3: 32\u201335","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3"},{"key":"key\n\t\t\t\t20180109102455_R26","doi-asserted-by":"crossref","unstructured":"Deftos LJ, Wolfert RL, Hill CS, Burton DW. Two\u2010site assays of bone gla protein (osteocalcin) demonstrate immunochemical heterogeneity of the intact molecule. Clin Chem1992; 38: 2318\u20132321","DOI":"10.1093\/clinchem\/38.11.2318"},{"key":"key\n\t\t\t\t20180109102455_R27","doi-asserted-by":"crossref","unstructured":"Gundberg CM, Weinstein RS. Multiple immunoreactive forms of osteocalcin in uremic serum. J Clin Invest1986; 77: 1762\u20131777","DOI":"10.1172\/JCI112499"},{"key":"key\n\t\t\t\t20180109102455_R28","doi-asserted-by":"crossref","unstructured":"Price PA, Nishimoto SK. Radioimmunoassay for the vitamin K\u2010dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci USA1980; 1980: 2234\u20132238","DOI":"10.1073\/pnas.77.4.2234"},{"key":"key\n\t\t\t\t20180109102455_R29","doi-asserted-by":"crossref","unstructured":"Jarava C, Armas JR, Salgueira M, Palma A. Bone alkaline phosphatase isoenzyme in renal osteodystrophy. Nephrol Dial Transplant1996; 11 [Suppl 3]: 43\u201346","DOI":"10.1093\/ndt\/11.supp3.43"},{"key":"key\n\t\t\t\t20180109102455_R30","doi-asserted-by":"crossref","unstructured":"Sebert JL, Marie A, Gueris J et al. Assessment of the aluminum overload and of its possible toxicity in asymptomatic uremic patients. evidence for a depressive effect on bone formation. Bone1985; 6: 373\u2013375","DOI":"10.1016\/8756-3282(85)90335-7"},{"key":"key\n\t\t\t\t20180109102455_R31","unstructured":"D'Haese PC, Couttenye MM, Goodman WG et al. Use of the low\u2010dose desferrioxamine test to diagnose and differentiate between patients with aluminium\u2010related bone disease, increased risk for aluminium toxicity, or aluminium overload. Nephrol Dial Transplant1995; 10: 1874\u20131884"},{"key":"key\n\t\t\t\t20180109102455_R32","doi-asserted-by":"crossref","unstructured":"Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y. Relationship between intact 1\u201384 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis1995; 26: 836\u2013844","DOI":"10.1016\/0272-6386(95)90453-0"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/15\/5\/659\/23367641\/150659.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T11:15:32Z","timestamp":1733656532000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/15\/5\/659\/1849920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5,1]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2000,5]]},"published-print":{"date-parts":[[2000,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/15.5.659","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"type":"electronic","value":"1460-2385"},{"type":"print","value":"0931-0509"}],"subject":[],"published-other":{"date-parts":[[2000,5]]},"published":{"date-parts":[[2000,5,1]]}}}